ATE173162T1 - Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen - Google Patents

Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen

Info

Publication number
ATE173162T1
ATE173162T1 AT94112012T AT94112012T ATE173162T1 AT E173162 T1 ATE173162 T1 AT E173162T1 AT 94112012 T AT94112012 T AT 94112012T AT 94112012 T AT94112012 T AT 94112012T AT E173162 T1 ATE173162 T1 AT E173162T1
Authority
AT
Austria
Prior art keywords
medicinal
administration
medical device
homeopatical
active substances
Prior art date
Application number
AT94112012T
Other languages
English (en)
Inventor
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Application granted granted Critical
Publication of ATE173162T1 publication Critical patent/ATE173162T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94112012T 1993-09-02 1994-08-02 Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen ATE173162T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (1)

Publication Number Publication Date
ATE173162T1 true ATE173162T1 (de) 1998-11-15

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94112012T ATE173162T1 (de) 1993-09-02 1994-08-02 Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen

Country Status (12)

Country Link
US (1) US5683712A (de)
EP (1) EP0641561B1 (de)
JP (1) JPH07165566A (de)
KR (1) KR950007808A (de)
AT (1) ATE173162T1 (de)
CA (1) CA2129760A1 (de)
DE (1) DE69414502T2 (de)
DK (1) DK0641561T3 (de)
ES (1) ES2125380T3 (de)
GR (1) GR3029308T3 (de)
IT (1) IT1261849B (de)
ZA (1) ZA946698B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
JP2009518307A (ja) 2005-12-01 2009-05-07 ユニバーシティ オブ マサチューセッツ ロウエル ボツリヌス菌ナノエマルジョン
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
WO2008039245A2 (en) 2006-04-27 2008-04-03 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
AU2007261782A1 (en) * 2006-06-06 2007-12-27 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
SG177184A1 (en) 2006-12-01 2012-01-30 Anterios Inc Amphiphilic entity nanoparticles
EP2091516A2 (de) 2006-12-01 2009-08-26 Anterios, Inc. Peptid-nanopartikel und verwendungen davon
AU2008228903B2 (en) 2007-03-19 2013-03-07 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin B12
KR20100050443A (ko) 2007-05-31 2010-05-13 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
SG10201608732VA (en) 2008-06-26 2016-12-29 Anterios Inc Dermal delivery
CA2804967A1 (en) 2010-07-15 2012-02-09 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
US9308275B2 (en) 2010-07-15 2016-04-12 Oleg Iliich Epshtein Method of increasing the effect of an activated-potentiated form of an antibody
CN103096927A (zh) 2010-07-15 2013-05-08 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及治疗胃肠道功能性疾病或病症的方法
JP6158082B2 (ja) 2010-07-17 2017-07-05 メルク パテント ゲーエムベーハー 浸透と作用の増強
US8987206B2 (en) 2010-07-21 2015-03-24 Oleg Iliich Epshtein Method of treating attention deficit hyperactivity disorder
CA2805978C (en) 2010-07-21 2016-06-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
KR20140003573A (ko) 2011-01-24 2014-01-09 안테리오스, 인코퍼레이티드 오일 조성물
CN106924216A (zh) 2011-01-24 2017-07-07 安特里奥公司 纳米颗粒组合物、其制剂和它们的用途
ES2720648T3 (es) 2011-01-24 2019-07-23 Anterios Inc Composiciones de nanopartículas
WO2012119102A2 (en) * 2011-03-03 2012-09-07 Cearna Inc. Homeopathic therapeutic method and compositions
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
CA2866460C (en) 2011-03-10 2021-03-09 Rigel Pharmaceuticals, Inc. 2,4 substituted pyrimidinediamines for use in discoid lupus
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) * 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
WO2014043257A1 (en) 2012-09-12 2014-03-20 Rigel Pharmaceuticals, Inc. Treatment for vitiligo
EP2981285B1 (de) 2013-04-03 2020-06-03 N-Fold Llc Neuartige nanopartikelzusammensetzungen
WO2015168564A1 (en) 2014-05-01 2015-11-05 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
CA2993288A1 (en) 2015-07-24 2017-02-02 Glaxo Group Limited Treatment for vitiligo
CA3044219A1 (en) 2016-11-21 2018-05-24 Eirion Therapeutics, Inc. Transdermal delivery of large agents
EP3728295A1 (de) 2017-12-20 2020-10-28 Allergan, Inc. Botulinumtoxin-zellbindungsdomänen-polypeptide und verfahren zur verwendung für behandlungen von fibrose-assoziierten erkrankungen
JP2022500452A (ja) 2018-09-13 2022-01-04 エイリオン セラピューティクス, インコーポレイテッド プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI−1)阻害剤(inhibitor)の使用
CN113056268A (zh) 2018-09-13 2021-06-29 艾里奥治疗公司 纤溶酶原激活物抑制剂1(pai-1)抑制剂和其用途
WO2020117564A1 (en) 2018-12-03 2020-06-11 Eirion Therapeutics, Inc. Improved delivery of large agents
US20220296503A1 (en) 2019-05-14 2022-09-22 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
EP0641561B1 (de) 1998-11-11
DK0641561T3 (da) 1999-07-26
ES2125380T3 (es) 1999-03-01
EP0641561A3 (de) 1995-09-27
JPH07165566A (ja) 1995-06-27
KR950007808A (ko) 1995-04-15
DE69414502D1 (de) 1998-12-17
IT1261849B (it) 1996-06-03
GR3029308T3 (en) 1999-05-28
ITRM930591A0 (it) 1993-09-02
ITRM930591A1 (it) 1995-03-02
EP0641561A2 (de) 1995-03-08
CA2129760A1 (en) 1995-03-03
ZA946698B (en) 1995-05-02
US5683712A (en) 1997-11-04
DE69414502T2 (de) 1999-04-08

Similar Documents

Publication Publication Date Title
ATE173162T1 (de) Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
DE3685895T2 (de) Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
ATE89755T1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
ES2062093T3 (es) Emplasto de varias capas.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
DE69225135T2 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
ATE78707T1 (de) Transdermale arzneimitteleinzeldosis gegen angina und verfahren zu ihrer verabreichung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee